Searched for
RECURSION PHARMACEUTICALS IPO
Lure of diversification, higher returns and global exposure driving Indian investors to US markets: Subho MoulikSubho Moulik, CEO of Appreciate, explains the increased interest of Indian investors in US markets, emphasizing diversification, higher ret...- Recursion Pharmaceuticals expands IPO to raise $436 millionThe Salt Lake City-based company sold about 24 million shares on Thursday for $18 each, according to data compiled by Bloomberg. The compan...
- Load More